“More than half of BIO’s member companies that are working on a coronavirus vaccine appear to be small businesses, which are highly dependent on raising venture funding. That’s risky enough already, but if it appears the government’s going to impose an artificial price cap if they discover a vaccine, companies like this could be discouraged from entering the race.”
